Cargando…
Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588661/ https://www.ncbi.nlm.nih.gov/pubmed/37861386 http://dx.doi.org/10.18632/oncotarget.28530 |
| _version_ | 1785123628160909312 |
|---|---|
| author | Mahalingam, Devalingam Hanni, Salih Serritella, Anthony V. Fountzilas, Christos Michalek, Joel Hernandez, Brian Sarantopoulos, John Datta, Paromitta Romero, Ofelia Achutan Pillai, Sureshkumar Mulampurath Kuhn, John Pollak, Michael Thompson, Ian M. |
| author_facet | Mahalingam, Devalingam Hanni, Salih Serritella, Anthony V. Fountzilas, Christos Michalek, Joel Hernandez, Brian Sarantopoulos, John Datta, Paromitta Romero, Ofelia Achutan Pillai, Sureshkumar Mulampurath Kuhn, John Pollak, Michael Thompson, Ian M. |
| author_sort | Mahalingam, Devalingam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10588661 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105886612023-10-21 Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer Mahalingam, Devalingam Hanni, Salih Serritella, Anthony V. Fountzilas, Christos Michalek, Joel Hernandez, Brian Sarantopoulos, John Datta, Paromitta Romero, Ofelia Achutan Pillai, Sureshkumar Mulampurath Kuhn, John Pollak, Michael Thompson, Ian M. Oncotarget Correction Impact Journals LLC 2023-10-19 /pmc/articles/PMC10588661/ /pubmed/37861386 http://dx.doi.org/10.18632/oncotarget.28530 Text en Copyright: © 2023 Mahalingam et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Mahalingam, Devalingam Hanni, Salih Serritella, Anthony V. Fountzilas, Christos Michalek, Joel Hernandez, Brian Sarantopoulos, John Datta, Paromitta Romero, Ofelia Achutan Pillai, Sureshkumar Mulampurath Kuhn, John Pollak, Michael Thompson, Ian M. Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer |
| title | Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer |
| title_full | Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer |
| title_fullStr | Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer |
| title_full_unstemmed | Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer |
| title_short | Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer |
| title_sort | correction: utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (adt): a randomized phase ii study of metformin in non-diabetic men initiating adt for advanced prostate cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588661/ https://www.ncbi.nlm.nih.gov/pubmed/37861386 http://dx.doi.org/10.18632/oncotarget.28530 |
| work_keys_str_mv | AT mahalingamdevalingam correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT hannisalih correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT serritellaanthonyv correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT fountzilaschristos correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT michalekjoel correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT hernandezbrian correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT sarantopoulosjohn correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT dattaparomitta correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT romeroofelia correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT achutanpillaisureshkumarmulampurath correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT kuhnjohn correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT pollakmichael correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer AT thompsonianm correctionutilizingmetformintopreventmetabolicsyndromeduetoandrogendeprivationtherapyadtarandomizedphaseiistudyofmetformininnondiabeticmeninitiatingadtforadvancedprostatecancer |